AXON Neuroscience Company Profile, Contacts & Intelligence
AXON Neuroscience Overview
AXON Neuroscience is a clinical-stage biotech company founded in 1999 with a specialized team of researchers focused exclusively on tau immunotherapies and tau diagnostic platforms. AXON has identified and wholly owns several compounds which are being investigated as potentially disease-modifying therapies for the treatment of Alzheimer's disease and other tauopathies. The two lead compounds are the active vaccine AADvac1 and the monoclonal antibody AADvac2. The tau vaccine AADvac1 has potential to be the first breakthrough therapy to address Alzheimer's disease and help millions of people suffering from the devastating disease. Axon is also developing a suite of diagnostic assays to more accurately identify patients with potential tau-derived brain diseases that can benefit from its novel therapeutic candidates.
- Headquarters
- Bratislava, Bratislavský Kraj, Sk
- Website
- axon-neuroscience.eu
- Industry
- Biotechnology Research
- Founded
- 1999
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
AXON Neuroscience Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
AXON Neuroscience People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
AXON Neuroscience Workforce Composition
Seniority breakdown across 13 visible profiles.
Compare Similar Companies to AXON Neuroscience
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Biogen | Biotechnology Research | 7.60K | View company |
| Evotec | Biotechnology Research | 4.90K | View company |
| Mitsubishi Tanabe Pharma Corporation | Pharmaceutical Manufacturing | 305 | View company |
| AC Immune | Biotechnology Research | 178 | View company |
| FutureNeuro | Research | 21 | View company |
| Receptos, a wholly-owned subsidiary of Celgene | Biotechnology Research | 20 | View company |
| Ulysses Neuroscience Limited | Pharmaceutical Manufacturing | 11 | View company |
| Oligomerix, Inc | Biotechnology Research | 10 | View company |
| Neuralstem, Inc. | Biotechnology | Not listed | View company |
| Neurotrope Inc. | Pharmaceutical Manufacturing | Not listed | View company |